NCT05766332View on ClinicalTrials.gov

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

November 17, 2023

Study Completion Date

November 17, 2023

Conditions
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Clinical Evaluation

Undergo clinical evaluation

OTHER

Electronic Health Record Review

Medical records reviewed

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05766332 - Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant | Biotech Hunter | Biotech Hunter